Group items tagged

With the upcoming general election on the horizon, Proprietary Association of Greater Britain (PAGB) is leading the charge to integrate self-care into the core of all political party manifestos. The aim is to ease strains on the NHS and forge a sustainable healthcare system for the future. In a significant move, PAGB unveiled a comprehensive general election toolkit on Wednesday, laying out a compelling argument for the prioritisation of self-care among stakeholders. The toolkit underscores the importance of public interest, potential NHS cost savings, and the economic advantages of the over-the-counter (OTC) sector. Aimed at unlocking the full potential of self-care and nurturing an enabling environment for its implementation, PAGB's toolkit advocates for greater integration of pharmacy services into primary care.

Shoulder pain is one of the most common types of pain that impacts your mobility and daily activities. Often associated with heart disease, shoulder pain can also occur due to an injury, trauma, or a medical condition like arthritis. While over-the-counter medications might help relieve the pain, it is crucial to address the cause of the pain becoming frequent. In this guide, we will be sharing particular situations that require a visit to an orthopedic doctor so you can get the appropriate treatment. AFTER AN ACCIDENT Minor injuries and accidents can cause inflammation and pain at the injury site which can be resolved by taking OTC medications and giving the body time to heal. However, in severe injuries, the joint may get swollen in an instant, cause extreme pain, or may seem deformed. In situations like these, there is a likelihood of a fracture and the injury then needs to be evaluated by a specialist. Depending on the severity of the accident, either the shoulder will be immobilized or operated on to repair the damage. If you have a broken shoulder, get plenty of rest, eat healthily, and follow your doctor's instructions for a quick recovery.

Drugmaker Viatris said on Sunday (October 1) it had reached agreements to divest some of its businesses for a total of about £2.9 billion. Viatris said its move to divest some of its businesses is part of its long-term strategy to streamline focus on three core therapeutic areas - ophthalmology, gastroenterology and dermatology. The company has received an offer of about $2.17 billion (£1.78 billion) for almost all of its over-the-counter drug business from France-based Cooper Consumer Health. Viatris will retain rights for erectile dysfunction drug Viagra, nasal spray Dymista and select OTC drugs within certain markets. Separately, the drugmaker said it has agreed to sell its women's healthcare business to Spanish pharmaceutical company Insud Pharma, while its active pharmaceutical ingredients business in India will be sold to Iquest Enterprises. Both divestitures would result in about $1.2 billion (£987 million) in proceeds.